Comparison between Newjaisa Technologies IPO and Saakshi Medtech IPO.
Newjaisa Technologies IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Saakshi Medtech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Newjaisa Technologies IPO | Saakshi Medtech IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Indorient Financial Services Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Newjaisa Technologies IPO is up to ₹37.93 Cr whereas the issue size of the Saakshi Medtech IPO is up to ₹42.88 Cr. The final issue price of Newjaisa Technologies IPO is ₹47.00 per share and of Saakshi Medtech IPO is ₹97.00 per share.
| Newjaisa Technologies IPO | Saakshi Medtech IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ₹44.00 per share | ₹92.00 per share |
| Issue Price (Upper) | ₹47.00 per share | ₹97.00 per share |
| Issue Price (Final) | ₹47.00 per share | ₹97.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1200 shares |
| Fresh Issue Size | 80,70,000 shares | 44,20,800 shares |
| Fresh Issue Size (Amount) | up to ₹37.93 Cr | up to ₹42.88 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 80,70,000 shares | 44,20,800 shares |
| Issue Size Total (Amount) | up to ₹37.93 Cr | up to ₹42.88 Cr |
Newjaisa Technologies IPO opens on Sep 25, 2023, while Saakshi Medtech IPO opens on Sep 25, 2023. The closing date of Newjaisa Technologies IPO and Saakshi Medtech IPO is Sep 27, 2023, and Sep 27, 2023, respectively.
| Newjaisa Technologies IPO | Saakshi Medtech IPO | |
|---|---|---|
| Anchor Bid Date | Sep 22, 2023 | Sep 22, 2023 |
| Issue Open | Sep 25, 2023 | Sep 25, 2023 |
| Issue Close | Sep 27, 2023 | Sep 27, 2023 |
| Basis Of Allotment (Tentative) | Oct 04, 2023 | Oct 03, 2023 |
| Initiation of Refunds (Tentative) | Oct 05, 2023 | Oct 04, 2023 |
| Credit of Share (Tentative) | Oct 06, 2023 | Oct 05, 2023 |
| Listing date (Tentative) | Oct 05, 2023 | Oct 03, 2023 |
| Anchor Lockin End date 1 | Nov 03, 2023 | Nov 02, 2023 |
| Anchor Lockin End date 2 | Jan 02, 2024 | Jan 01, 2024 |
Newjaisa Technologies IPO P/E ratio is 15.51, as compared to Saakshi Medtech IPO P/E ratio of 10.18.
| Newjaisa Technologies IPO | Saakshi Medtech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 94.23 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 15.51 | 10.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹151.26 Cr. | ₹171.26 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 72.63% | 34.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 72.63% | 28.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.03 | ₹9.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 72.63% | 29.32% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Newjaisa Technologies IPO Retail Individual Investors (RII) are offered 28,26,000 shares while in Saakshi Medtech IPO retail investors are offered 28,26,000 shares. Qualified Institutional Buyers (QIB) are offered 16,14,000 shares in Newjaisa Technologies IPO and 8,84,400 shares in Saakshi Medtech IPO.
| Newjaisa Technologies IPO | Saakshi Medtech IPO | |
|---|---|---|
| Anchor Investor Reservation | 24,18,000 shares | 13,24,800 shares |
| Market Maker Reservation | 4,26,000 shares | 2,35,200 shares |
| QIB | 16,14,000 shares | 8,84,400 shares |
| NII | 12,12,000 shares | 6,63,600 shares |
| RII | 28,26,000 shares | 15,48,000 shares |
| Employee | ||
| Others | ||
| Total | 80,70,000 shares | 44,20,800 shares |
Newjaisa Technologies IPO subscribed 6.85x in total, whereas Saakshi Medtech IPO subscribed 91.65x.
| Newjaisa Technologies IPO | Saakshi Medtech IPO | |
|---|---|---|
| QIB (times) | 1.02x | 37.35x |
| NII (times) | 15.34x | 200.78x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 6.54x | 75.88x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 6.85x | 91.65x |
